A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Three former European Commissioners warn that scrapping social protections in pursuit of competitiveness will leave the Union ...

As communication networks become increasingly intelligent, software-defined, and security-intensive, the Indian Institute of ...

However, the transition to solar technology requires a sophisticated understanding of how decorative forms impact technical performance. Finding a reliable Custom Solar Post Top Garden Light Exporter ...

Discover the 10 easiest crypto to mine in 2026 for beginners and pros. Earn digital assets with minimal setup and high ...

Good morning, everyone, and thank you for joining us today. Welcome to our half year results. We've delivered another very strong half with operating profit up by 12%. This performance reflects a ...

Large Language Models (LLMs) such as GPT-4, Gemini-Pro, Llama 2, and medical-domain-tuned variants like Med-PaLM 2 have ...

Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash deal worth $4.1 billion. The acquisition ...

Aims To evaluate whether predominantly peripheral lesions (PPLs) and other imaging biomarkers on ultra-widefield (UWF) ...

Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...

In 2026, AI-powered wearables are evolving from passive trackers into clinically validated, proactive health partners. Backed by medical-grade accuracy and shaped by new FDA guidance, devices like the ...